OTC : CDBT
$0 (0.0%)
OTC
Gang Chen
Shell Companies
Financial Services
CDBT
689
CN
USD
-0.85
0.07
0.07
0.00
0.00
-$
0.00
-3.38
-17.54
-0.01
-$0.0236
-$967K
0.00%
0.00%
155.49%
-202.74%
-4.24
0.06
0.06
0/5
0 Analysts
%
-9.38
2/9
-$1.06M
$420.22K
$1.18M
-$288.96K
$5.12M
0.00
-8.04
0.07
155.49%
354.68%
-23.60%
-5.70%
0 days
| Name | Title |
|---|---|
| Jinjun Qi | President & Secretary |
| Gang Chen | Chairman of the Board & Chief Executive Officer |
| Hongsheng Wang | Chief Financial Officer |
| Jingbo Gao | Vice President of Investor Relations |
No votes yet today — be the first to share your view!
About China Dasheng Biotechnology Company (OTC:CDBT) Stock
China Dasheng Biotechnology Company, alongside its various divisions, is dedicated to the creation, promotion, and distribution of microbial products within the People's Republic of China. These specialized solutions primarily function as beneficial additives for both livestock feed and agricultural cultivation. The company's product line features proprietary blends of Artificial Microorganisms (AM) and High-efficiency Microorganisms (HM), in addition to biological preservatives. Its AM/HM bacteria-based additives for crops, including specific strains like Bulgaria lactobacillus, beer microzyme, and dark red spirilla, are formulated to significantly boost beneficial microbial populations in soil. They also work to counteract the proliferation of harmful fungi and putrefactive bacteria, the ... reby optimizing nutrient absorption and helping to reduce the incidence of diseases in both plants and animals. For animal nutrition, the AM/HM bacteria-based feed additives are designed to improve the texture of livestock feed and inhibit the growth of pathogenic bacteria. Moreover, they deliver essential nutrients such as organic acids, vitamins, enzymes, natural antibiotics, mycelial protein, and various other growth-promoting substances to ensure a balanced nutritional profile in the feed. The FGW bacterial preservatives serve a dual purpose: preserving animal specimens for scientific research and extending the shelf life of agricultural produce. Furthermore, the company supplies bacteria-based fertilizers intended for application directly onto plant foliage, particularly for vegetables and fruits. Beyond its biotechnology endeavors, China Dasheng Biotechnology Company also holds investments in the residential and commercial real estate sectors. The enterprise was previously known as Max Nutrition, Inc., before officially adopting its current name, China Dasheng Biotechnology Company, in March 2008. Its operational headquarters are situated in Lanzhou, China.
Frequently Asked Questions
What is the current China Dasheng Biotechnology Company (CDBT) stock price?
China Dasheng Biotechnology Company(OTC:CDBT) stock price is $0.1 in the last trading session. During the trading session, CDBT stock reached the peak price of $0.15 while $0.0003 was the lowest point it dropped to. The percentage change in CDBT stock occurred in the recent session was 0.0% while the dollar amount for the price change in CDBT stock was $0.
CDBT's industry and sector of operation?
The OTC listed CDBT is part of Shell Companies industry that operates in the broader Financial Services sector.
Who are the executives of CDBT?
Jinjun Qi
| President & Secretary
Gang Chen
| Chairman of the Board & Chief Executive Officer
Hongsheng Wang
| Chief Financial Officer
Jingbo Gao
| Vice President of Investor Relations
|
How many employees does CDBT have?
Number of CDBT employees currently stands at 689. CDBT operates from Building B, Lanzhou, None None, CN.
Link for CDBT official website?
Official Website of CDBT is: http://www.chinadashengbio.com
How do I contact CDBT?
CDBT could be contacted at phone #86 93 1844 1248 and can also be accessed through its website. CDBT operates from Building B, Lanzhou, None None, CN.
How many shares of CDBT are traded daily?
The average number of CDBT shares traded daily for last 3 months was 6.03K.
What is the market cap of CDBT currently?
The market value of CDBT currently stands at $4.1M with its latest stock price at $0.1